Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19Erin K McCreary, Kevin E. Kip, Mary Kay Wisniewski et al.|JAMA Network Open|2022Cited by 36
Association of subcutaneous or intravenous route of administration of casirivimab and imdevimab monoclonal antibodies with clinical outcomes in COVID-19Erin K McCreary, Kevin E. Kip, J Ryan Bariola et al.|medRxiv|2021Cited by 6